Compare JD.Com Inc (JD) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JD.Com Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? JD.Com Inc trades at $27.32 (market cap $36.62B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.68 (market cap $2.27B). The key difference: JD.Com Inc is far larger — about 16.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and JD.Com Inc pays a 3.72% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| JD | SLS | |
|---|---|---|
Market Cap | $36.62B | $2.27B |
Volume | 6,571,477 | 4,179,659 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.53 | $15.46 |
52-Week Low | $25.19 | $1.39 |
Typical Hold Time | 85 Days | — |
Enterprise Value | $19.26B | $2.14B |
Dividend Yield | 3.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JD.com stock trades at $27.03, up 2.0% today, with a bullish technical signal and strong analyst consensus. The company reported revenue of $1.31 trillion in 2025, though net income declined to $19.63 billion. Recent news highlights potential EU approval for its $2.5 billion Ceconomy acquisition, a key strategic move.
The outlook is positive given deep valuation discounts (P/E 17.9, P/S 0.2) and robust cash flow, but risks include revenue pressure and regulatory scrutiny. Analyst price targets average $35.86, implying significant upside from current levels if execution improves.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
